Highbridge Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,825
| Closed | -$383K | – | 866 |
|
|
2018
Q1 | $383K | Hold |
10,825
| – | – | 0.01% | 559 |
|
|
2017
Q4 | $420K | Buy |
+10,825
| New | +$420K | 0.01% | 544 |
|
|
2017
Q3 | – | Sell |
-7,500
| Closed | -$205K | – | 1070 |
|
|
2017
Q2 | $205K | Sell |
7,500
-6,492
| -46% | -$177K | ﹤0.01% | 740 |
|
|
2017
Q1 | $463K | Sell |
13,992
-2,144
| -13% | -$70.9K | 0.01% | 743 |
|
|
2016
Q4 | $384K | Sell |
16,136
-846
| -5% | -$20.1K | 0.01% | 716 |
|
|
2016
Q3 | $623K | Buy |
+16,982
| New | +$623K | 0.01% | 617 |
|
|
2015
Q2 | – | Sell |
-10,196
| Closed | -$364K | – | 1048 |
|
|
2015
Q1 | $364K | Buy |
+10,196
| New | +$364K | 0.01% | 633 |
|
|
2014
Q2 | – | Sell |
-6,773
| Closed | -$263K | – | 887 |
|
|
2014
Q1 | $263K | Buy |
+6,773
| New | +$263K | ﹤0.01% | 612 |
|